antigen-specific antibody response in juvenile-onset sle patients following routine immunization with tetanus toxoid

نویسندگان

sara kashef

allergy research center farid ghazizadeh

department of pediatric, division of immunology and allergy ali derakhshan

department of pediatric, division of nephrology shirin farjadian

allergy research center soheila alyasin

چکیده

background: infection is now the most common cause of morbidity in systemic lupus erythematosus (sle). there is lack of information regarding the specific antibody forma-tion in response to vaccines in young sle patients. objective: to determine the efficacy of anti-tetanus antibody response in young patients with sle. methods: forty sle pa-tients with mean age of 14.1 years (range: 7-21) and 60 age and sex matched normal con-trols were enrolled in this study over a period of one year. diagnosis was made according to the acr criteria and disease activity was determined based on sle disease activity index (sledai). all patients and controls had received the complete schedule of tetanus vaccinations consisting of three primary doses and two boosters by the age of six. serum immunoglobulins and anti-tetanus antibody titers were determined by nephelometry and elisa. anti-tetanus antibody levels greater than 0.1 iu/ml have been suggested as pro-tective. results: in all of the patients and controls anti-tetanus antibody titer was > 0.1 iu/ml. igg, iga, and igm levels were in the normal range for their age. mean disease ac-tivity score was 4.9 (range: 0-16). there was no association between sledai score and anti-tetanus antibody response. conclusion: school age onset and immunosuppressive therapy does not seem to interfere with development of consistent immunity to tetanus vaccine in young sle patients.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Antigen-Specific Antibody Response in Juvenile-Onset SLE Patients Following Routine Immunization with Tetanus Toxoid

Background: Infection is now the most common cause of morbidity in Systemic Lupus Erythematosus (SLE). There is lack of information regarding the specific antibody forma-tion in response to vaccines in young SLE patients. Objective: To determine the efficacy of anti-tetanus antibody response in young patients with SLE. Methods: Forty SLE pa-tients with mean age of 14.1 years (range: 7-21) and 6...

متن کامل

Immunization with Tetanus Toxoid

Although immunization with tetanus toxoid cannot be expected to produce an adequate permanent immunity, a number of investigators have confirmed and extended the observation of Ramon3 to the effect that an organism, once immunized, will respond to further injections of toxoid with an accelerated and increased antitoxin production. That this response to the "injection de rappel" does occur has b...

متن کامل

Tetanus toxoid immunization to reduce mortality from neonatal tetanus

BACKGROUND Neonatal tetanus remains an important and preventable cause of neonatal mortality globally. Large reductions in neonatal tetanus deaths have been reported following major increases in the coverage of tetanus toxoid immunization, yet the level of evidence for the mortality effect of tetanus toxoid immunization is surprisingly weak with only two trials considered in a Cochrane review. ...

متن کامل

Aerosol immunization of guinea pigs with fluid tetanus toxoid.

The concept of mass vaccination of large populations by inhalation of a vaccine in the form of an aerosol [Aleksandrov and Gefen, J. Microbiol. Epidemiol. Immunobiol. (USSR) 31:997, 1960; Sawyer, Kuehne, and Gochenour, Military Med. 129:1040, 1964] has a strong appeal. Aerosol vaccination could immunize a maximal number of people in a minimal period of time, and possibly could confer superior p...

متن کامل

Studies on Tetanus Toxoid: III. Antitoxic Response in Guinea Pigs Immunized with Tetanus Alum-precipitated Toxoid Followed by Tetanus Spores.

When an individual has been given one or more injections of tetanus toxoid and, at a later date, is injured and possibly infected with Clostridium tetani, what further precautions should be taken: (1) Administer antitoxin? (2) Give another injection of tetanus toxoid to accelerate the production of antitoxin? (3) Give no further treatment, depending on his present immunity to take care of the i...

متن کامل

Human Dermal Fibroblasts Present Tetanus Toxoid Antigen

Cultured human dermal fibroblasts treated with immune interferon express HLA-DR antigens. We report here that DRpositive fibroblasts present tetanus toxoid (TT) to autologous TT-specific monoclonal helper T cells vigorously depleted of monocytes by passage over Sephadex G10 columns followed by treatment with the monoclonal antibodies (mAb) OKMl and Leu Ml plus complement. The extent of T cell p...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of immunology

جلد ۵، شماره ۳، صفحات ۱۸۱-۱۸۴

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023